drugset / Trial / NCT05995769
Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
Phase 2
Recruiting
128 enrolled
University of Calgary
Canadian Institutes of Health Research (CIHR) · collabJohns Hopkins University · collabUniversity of Maryland · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD).
Timeline
- Start
- 2024-03-20
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 1 mg | Oral |
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |